Yarrow Bioscience Inc. (YARW)
YARW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$18.60
-6.16% on the day
Market cap
$173.1M
Micro cap
Revenue · 2025
$570K
+13.8% on 2024
Net income · 2025
-$26.5M
-4646.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | YARW on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001566044 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $570K |
| Net income | -$26.5M |
| Operating income | -$29.7M |
| Net margin | -4646.1% |
| Operating margin | -5219.1% |
| Revenue growth | +13.8% |
| Cash | $24.0M |
| Total assets | $30.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 303.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-11 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-09-14 |
| Latest proxy | DEF 14A | 2025-11-12 |
Source: SEC EDGAR submissions feed, 677 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
| NGEN | NervGen Pharma Corp. | $1.63 | -5.78% | $173.5M |
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| WHWK | Whitehawk Therapeutics Inc. | $3.02 | -10.65% | $172.2M |
| VRXA | Veraxa Biotech AG | $1.20 | +5.26% | $169.7M |
| LYEL | Lyell Immunopharma Inc. | $7.51 | -9.19% | $184.0M |
| ADAG | Adagene Inc. | $2.46 | -10.22% | $162.5M |
| CNTN | Canton Strategic Holdings Inc. | $2.02 | -4.26% | $161.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier